• Study of DNAJB1-PRKACA Peptide Vaccine for Patients with Fibrolamellar Hepatocellular Carcinoma and Other Tumors with Oncogenic Driver Fusion

    Recruiting

    1 1 1
    Investigated Diseases:
    Germany
  • Study on Verapamil to Preserve Insulin Secretion in Children with Recent Onset Type 1 Diabetes

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • Study on the Effectiveness of Adding Progesterone to Chemotherapy with Etoposide, Doxorubicin, Cisplatin, and Mitotane for Advanced Adrenocortical Carcinoma Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    Italy
  • Study of Atezolizumab, Carboplatin, and Nab-Paclitaxel for Patients with Metastatic Triple-Negative PD-L1 Positive Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Study on the Effects of Amoxicillin on Post-Surgical Complications in Patients with Tooth Loss Undergoing Implant Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on the Effectiveness of Aripiprazole and Paliperidone in Patients Experiencing Their First Episode of Schizophrenia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study comparing oxaliplatin and irinotecan chemotherapy effectiveness using tumor testing in patients with metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Norway
  • Study on Long-term Safety of XTMAB-16 for Patients with Pulmonary Sarcoidosis with or without Extra-pulmonary Involvement

    Recruiting

    2 1 1
    Investigated Drugs:
    Czechia Denmark Italy Poland Spain
  • Study on Zoledronic Acid for Healing After Rotator Cuff Surgery in Patients with Tendon Rupture and Osteoporosis

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria
  • Study on Dalteparin Sodium and Enoxaparin Sodium for Preventing Blood Clots in Patients Undergoing Liver Surgery

    Recruiting

    3 1 1 1
    Norway

powered by